Monte Rosa Therapeutics, Inc. Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change
Monte Rosa Therapeutics, Inc. (GLUE) reported Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change of -$85.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanOtherChanges · last filed 2026-08-06
- Monte Rosa Therapeutics, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for the quarter ending 2026-06-30 was -$36.00K.
- Monte Rosa Therapeutics, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for the quarter ending 2026-03-31 was -$49.00K.
- Monte Rosa Therapeutics, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for the quarter ending 2025-12-31 was $147.00K, a 390.00% increase year-over-year.
- Monte Rosa Therapeutics, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for the quarter ending 2025-09-30 was -$235.00K.
- Monte Rosa Therapeutics, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for fiscal 2025 was -$1.04M.
- Monte Rosa Therapeutics, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for fiscal 2024 was -$187.00K, a 199.47% decline from fiscal 2023.
- Monte Rosa Therapeutics, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for fiscal 2023 was $188.00K.
- Monte Rosa Therapeutics, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for fiscal 2022 was -$74.00K.
| Period end | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change 3 month | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change 6 month | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change 9 month | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$85.00K 10-Q · filed 2026-08-06 | $62.00K derived: sum of 3 quarters · filed 2026-08-06 | -$173.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$49.00K 10-Q · filed 2026-05-07 | $98.00K derived: sum of 2 quarters · filed 2026-05-07 | -$137.00K derived: sum of 3 quarters · filed 2026-05-07 | -$787.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$88.00K derived: sum of 2 quarters · filed 2026-03-17 | -$738.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.04M 10-K · filed 2026-03-17 |
| 2025-09-30 | -$235.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$885.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.19M 10-Q · filed 2025-11-06 | -$1.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$650.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$957.00K 10-Q · filed 2026-08-06 | -$927.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$307.00K 10-Q · filed 2026-05-07 | -$277.00K derived: sum of 2 quarters · filed 2026-05-07 | -$523.00K derived: sum of 3 quarters · filed 2026-05-07 | -$604.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$216.00K derived: sum of 2 quarters · filed 2026-03-17 | -$297.00K derived: sum of 3 quarters · filed 2026-03-17 | -$187.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | -$246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$327.00K derived: sum of 2 quarters · filed 2025-11-06 | -$217.00K 10-Q · filed 2025-11-06 | -$68.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $29.00K 10-Q · filed 2025-08-07 | $178.00K derived: sum of 3 quarters · filed 2025-08-07 | $217.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $110.00K 10-Q · filed 2025-05-08 | $259.00K derived: sum of 2 quarters · filed 2025-05-08 | $298.00K derived: sum of 3 quarters · filed 2025-05-08 | $291.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $188.00K derived: sum of 2 quarters · filed 2025-03-20 | $181.00K derived: sum of 3 quarters · filed 2025-03-20 | $188.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $32.00K derived: sum of 2 quarters · filed 2024-11-07 | $39.00K 10-Q · filed 2024-11-07 | $15.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$24.00K derived: sum of 3 quarters · filed 2024-08-08 | -$46.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-09 | -$17.00K derived: sum of 2 quarters · filed 2024-05-09 | -$39.00K derived: sum of 3 quarters · filed 2024-05-09 | -$26.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$46.00K derived: sum of 2 quarters · filed 2024-03-14 | -$33.00K derived: sum of 3 quarters · filed 2024-03-14 | -$74.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$9.00K derived: sum of 2 quarters · filed 2023-11-09 | -$50.00K 10-Q · filed 2023-11-09 | -$1.16M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$28.00K 10-Q · filed 2023-08-10 | -$1.14M derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$41.00K 10-Q · filed 2023-05-11 | -$1.15M derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$1.11M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | -$1.07M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |